Core Viewpoint - The article highlights the rapid development of the biomedical industry in Hangzhou, particularly in the Hangzhou Medical Port Town, which has become a hub for over 1,800 biotech companies, including major global pharmaceutical firms and numerous innovative enterprises [3][8]. Group 1: Industry Development - The Hangzhou Medical Port Town covers an area of 4.92 square kilometers and hosts more than 1,800 biomedical enterprises, including leading global pharmaceutical companies such as Pfizer, Merck, and Bayer [3]. - The Zhejiang Free Trade Zone has been instrumental in promoting the biomedical industry, focusing on open innovation across the entire industry chain, aiming to establish Hangzhou as an international center for biomedical technology and innovation [3][6]. - The establishment of a joint regulatory mechanism for high-risk imported special items has significantly improved customs efficiency, reducing approval times from 20 working days to just 2 days, thus enhancing competitiveness in global drug development [5][8]. Group 2: Company Insights - Lianchuan Biotechnology, a key player in the gene technology sector, has been operating in Hangzhou for nearly 20 years and has developed a strong focus on high-throughput gene sequencing and bioinformatics services [4][6]. - The company has faced challenges with importing critical standards for its OLINK proteomics testing, which required Swedish plasma as a control standard, but has successfully navigated these challenges through the new regulatory framework [4][5]. - Lianchuan has expanded its operations significantly, establishing a nationwide research service network and entering the IPO stage on the Beijing Stock Exchange, serving over 90% of key universities in China [6][8]. Group 3: Innovation and Ecosystem - The integration of 14 universities and 250,000 students in the Qiantang District has created a robust talent pool, supporting the development of the biomedical industry [7]. - The establishment of high-level platforms such as the Zhejiang University Intelligent Innovative Drug Research Institute and the Pfizer Smart Medical Innovation Center has contributed to forming a complete industrial chain from research to commercialization [7]. - The Qiantang District has developed a comprehensive innovation ecosystem that covers basic research, technological breakthroughs, and industrialization, positioning itself as a critical player in the global biomedical landscape [7][8].